Al-Zahrani KN, Baron KD, Sabourin LA. 2013. Ste20-like kinase SLK, at the crossroads: a matter of life and death. Cell Adh Migr 7: 1-10.
Baixauli F, Lopez-Otin C, Mittelbrunn M. 2014. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol 5: 403.
Bebee TW, Cieply BW, Carstens RP. 2014. Genome-wide activities of RNA binding proteins that regulate cellular changes in the epithelial to mesenchymal transition (EMT). Adv Exp Med Biol 825: 267-302.
Belov AA, Mohammadi M. 2012. Grb2, a double-edged sword of receptor tyrosine kinase signaling. Sci Signal 5: e49.
Buljan M, Chalancon G, Eustermann S, Wagner GP, Fuxreiter M, Bateman A, Babu MM. 2012. Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks. Mol Cell 46: 871-883.
Buljan M, Chalancon G, Dunker AK, Bateman A, Balaji S, Fuxreiter M, Babu MM. 2013. Alternative splicing of intrinsically disordered regions and rewiring of protein interactions. Curr Opin Struct Biol 23: 443-450.
Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K, Walker CL. 2006. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 173: 279-289.
Cieply B, Carstens RP. 2015. Functional roles of alternative splicing factors in human disease. Wiley Interdiscip Rev RNA 6: 311-326.
Colak R, Kim T, Michaut M, Sun M, Irimia M, Bellay J, Myers CL, Blencowe BJ, Kim PM. 2013. Distinct types of disorder in the human proteome: functional implications for alternative splicing. PLoS Comput Biol 9: e1003030.
Corominas R, Yang X, Lin GN, Kang S, Shen Y, Ghamsari L, Broly M, Rodriguez M, Tam S, Trigg SA, et al. 2014. Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. Nat Commun 5: 3650.
Daguenet E, Dujardin G, Valcarcel J. 2015. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep 16: 1640-1655.
Dardenne E, Pierredon S, Driouch K, Gratadou L, Lacroix-Triki M, Espinoza MP, Zonta E, Germann S, Mortada H, Villemin JP, et al. 2012. Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness. Nat Struct Mol Biol 19: 1139-1146.
de Klerk E, 't Hoen PAC 2015. Alternative mRNA transcription, processing, and translation: insights from RNA sequencing. Trends Genet 31: 128-139.
Dinkel H, Chica C, Via A, Gould CM, Jensen LJ, Gibson TJ, Diella F. 2011. Phospho.ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res 39: D261-D267.
Du Y, Xu N, Lu M, Li T. 2011. hUbiquitome: a database of experimentally verified ubiquitination cascades in humans. Database 2011: bar055 p.
Ellis JD, Barrios-Rodiles M, Colak R, Irimia M, Kim T, Calarco JA, Wang X, Pan Q, O'Hanlon D, Kim PM, et al. 2012. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol Cell 46: 884-892.
Fukuchi S, Hosoda K, Homma K, Gojobori T, Nishikawa K. 2011. Binary classification of protein molecules into intrinsically disordered and ordered segments. BMC Struct Biol 11: 29.
Hamid FM, Makeyev EV. 2014. Emerging functions of alternative splicing coupled with nonsense-mediated decay. Biochem Soc Transac 42: 1168-1173.
Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, Latham V, Sullivan M. 2012. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally de-termined post-translational modifications in man and mouse. Nucleic Acids Res 40: D261-D270.
Huang KY, Su MG, Kao HJ, Hsieh YC, Jhong JH, Cheng KH, Huang HD, Lee TY. 2016. dbPTM 2016:10-year anniversary of a resource for post-trans-lational modification of proteins. Nucleic Acids Res 44: D435-D446.
Inoki K, Li Y, Zhu T, Wu J, Guan KL. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4: 648-657.
Isakson P, Holland P, Simonsen A. 2013. The role of ALFY in selective autophagy. Cell Death Differ 20: 12-20.
Jones DC, Roghanian A, Brown DP, Chang C, Allen RL, Trowsdale J, Young NT. 2009. Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. Eur J Immunol 39: 3195-3206.
Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, McWilliam H, Maslen J, Mitchell A, Nuka G, et al. 2014. InterProScan 5: genome-scale protein function classification. Bioinformatics 30: 1236-1240.
Kelemen O, Convertini P, Zhang Z, Wen Y, Shen M, Falaleeva M, Stamm S. 2013. Function of alternative splicing. Gene 514: 1-30.
Khaminets A, Behl C, Dikic I. 2016. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol 26: 6-16.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. JMol Biol 305: 567-580.
Ktistakis NT, Tooze SA. 2016. Digesting the expanding mechanisms of autophagy. Trends Cell Biol 26: 624-635.
Lamb CA, Yoshimori T, Tooze SA. 2013. The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol 14: 759-774.
Lee Y, Rio DC. 2015. Mechanisms and regulation of alternative pre-mRNA splicing. Annu Rev Biochem 84: 291-323.
Lev-Maor G, Goren A, Sela N, Kim E, Keren H, Doron-Faigenboim A, Leibman-Barak S, Pupko T, Ast G. 2007. The "alternative" choice of constitutive exons throughout evolution. PLoS Genet 3: e203.
Li HD, Menon R, Omenn GS, Guan Y. 2014. The emerging era of genomic data integration for analyzing splice isoform function. Trends Genet 30: 340-347.
Li HD, Omenn GS, Guan Y. 2015. MIsoMine: a genome-scale high-resolution data portal of expression, function and networks at the splice isoform level in the mouse. Database 2015: bav045.
Light S, Elofsson A. 2013. The impact of splicing on protein domain architecture. Curr Opin Struct Biol 23: 451-458.
Mall T, Eckstein J, Norris D, Vora H, Freese NH, Loraine AE. 2016. ProtAnnot: an App for Integrated Genome Browser to display how alternative splicing and transcription affect proteins. Bioinformatics 32: 2499-2501.
Mallinjoud P, Villemin JP, Mortada H, Polay Espinoza M, Desmet FO, Samaan S, Chautard E, Tranchevent LC, Auboeuf D. 2014. Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin. Genome Res 24: 511-521.
Matlock MK, Holehouse AS, Naegle KM. 2015. ProteomeScout: a repository and analysis resource for post-translational modifications and proteins. Nucleic Acids Res 43: D521-D530.
Matsunaga K, Noda T, Yoshimori T. 2009. Binding Rubicon to cross the Rubicon. Autophagy 5: 876-877.
Mitchell A, Chang HY, Daugherty L, Fraser M, Hunter S, Lopez R, McAnulla C, McMenamin C, Nuka G, Pesseat S, et al. 2015. The InterPro protein families database: the classification resource after 15 years. Nucleic Acids Res 43: D213-D221.
Montecchi-Palazzi L, Beavis R, Binz PA, Chalkley RJ, Cottrell J, Creasy D, Shofstahl J, Seymour SL, Garavelli JS. 2008. The PSI-MOD community standard for representation of protein modification data. Nat Biotechnol 26: 864-866.
Mudge JM, Frankish A, Fernandez-Banet J, Alioto T, Derrien T, Howald C, Reymond A, Guigo R, Hubbard T, Harrow J. 2011. The origins, evolution, and functional potential of alternative splicing in vertebrates. Mol Biol Evol 28: 2949-2959.
Mungall CJ, Batchelor C, Eilbeck K. 2011. Evolution of the Sequence Ontology terms and relationships. J Biomed Inform 44: 87-93.
Nilsen TW, Graveley BR. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463: 457-463.
Oates ME, Romero P, Ishida T, Ghalwash M, Mizianty MJ, Xue B, Dosztanyi Z, Uversky VN, Obradovic Z, Kurgan L, et al. 2013. D(2)P(2): database of disordered protein predictions. Nucleic Acids Res 41: D508-D516.
Oldfield CJ, Dunker AK. 2014. Intrinsically disordered proteins and intrinsically disordered protein regions. Annu Rev Biochem 83: 553-584.
Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, Campbell NH, Chavali G, Chen C, del-Toro N, et al. 2014. The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res 42: D358-D363.
Plass M, Eyras E. 2006. Differentiated evolutionary rates in alternative exons and the implications for splicing regulation. BMC Evol Biol 6: 50.
Raj B, Irimia M, Braunschweig U, Sterne-Weiler T, O'Hanlon D, Lin ZY, Chen GI, Easton LE, Ule J, Gingras AC, et al. 2014. A global regulatory mechanism for activating an exon network required for neurogenesis. Mol Cell 56: 90-103.
Rodriguez JM, Carro A, Valencia A, Tress ML. 2015. APPRIS WebServer and WebServices. Nucleic Acids Res 43: W455-W459.
Romero PR, Zaidi S, Fang YY, Uversky VN, Radivojac P, Oldfield CJ, Cortese MS, Sickmeier M, LeGall T, Obradovic Z, et al. 2006. Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc Natl Acad Sci 103: 8390-8395.
Samaan S, Tranchevent LC, Dardenne E, Polay Espinoza M, Zonta E, Germann S, Gratadou L, Dutertre M, Auboeuf D. 2014. The Ddx5 and Ddx17 RNA helicases are cornerstones inthe complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Res 42: 2197-2207.
Sebestyen E, Singh B, Minana B, Pages A, Mateo F, Pujana MA, Valcarcel J, Eyras E. 2016. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res 26: 732-744.
Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA, Soreq H. 2005. Function of alternative splicing. Gene 344: 1-20.
Tejedor JR, Papasaikas P, Valcarcel J. 2015. Genome-wide identification of Fas/CD95 alternative splicing regulators reveals links with iron homeo-stasis. Mol Cell 57: 23-38.
Tian B, Manley JL. 2013. Alternative cleavage and polyadenylation: the long and short of it. Trends Biochem Sci 38: 312-320.
Toker A. 2008. mTOR and Akt signaling in cancer: SGK cycles in. Mol Cell 31: 6-8.
Tseng YT, Li W, Chen CH, Zhang S, Chen JJ, Zhou X, Liu CC. 2015. IIIDB: a database for isoform-isoform interactions and isoform network modules. BMC Genomics 16: S10.
UniProt Consortium. 2015. UniProt: a hub for protein information. Nucleic Acids Res 43: D204-D212.
Uversky VN. 2015. Functional roles of transiently and intrinsically disor-dered regions within proteins. FEBS J 282: 1182-1189.
Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, Darnell RB, Massague J. 2014. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. eLife 3: e02734.
Venables JP, Brosseau JP, Gadea G, Klinck R, Prinos P, Beaulieu JF, Lapointe E, Durand M, Thibault P, Tremblay K, et al. 2013. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol Cell Biol 33: 396-405.
Wang J, Torii M, Liu H, Hart GW, Hu ZZ. 2011. dbOGAP-an integrated bio-informatics resource for protein O-GlcNAcylation. BMC Bioinformatics 12: 91.
Weatheritt RJ, Davey NE, Gibson TJ. 2012. Linear motifs confer functional diversity onto splice variants. Nucleic Acids Res 40: 7123-7131.
Wild P, McEwan DG, Dikic I. 2014. The LC3 interactome at a glance. J Cell Sci 127: 3-9.
Will T, Helms V. 2016. PPIXpress: construction ofcondition-specific protein interaction networks based on transcript expression. Bioinformatics 32: 571-578.
Yang X, Coulombe-Huntington J, Kang S, Sheynkman GM, Hao T, Richardson A, Sun S, Yang F, Shen YA, Murray RR, et al. 2016a. Widespread expansion of protein interaction capabilities by alternative splicing. Cell 164: 805-817.
Yang Y, Park JW, Bebee TW, Warzecha CC, Guo Y, Shang X, Xing Y, Carstens RP. 2016b. Determination of a comprehensive alternative splicing regulatory network and combinatorial regulation by key factors during the epithelial-to-mesenchymal transition. Mol Cell Biol 36: 1704-1719.
